Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
April 30, 2024
ECOX Signs Binding Agreements to Open Engineering and Construction Firm to Drive Canadian PoolCooled(TM) Commercial Launch
October 14, 2021
Related Post
-
-
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 30, 2024
-
NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease
April 29, 2024
-
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
April 26, 2024